New president of Merck Vaccines
This article was originally published in Scrip
Merck & Co has named Dr Julie Gerberding president of Merck Vaccines, effective January 25th. She will be responsible for the commercialisation of the company's portfolio of vaccines and accelerating Merck's ongoing efforts to broaden access to its vaccines in the developing world. Dr Gerberding led the US Centers for Disease Control and Prevention as director from 2002-09.